Clinical efficacy and safety in patients treated with teicoplanin with a target trough concentration of 20 μg/mL using a regimen of 12 mg/kg for five doses within the initial 3 days

BACKGROUND: A trough concentration (C(min)) ≥20 μg/mL of teicoplanin is recommended for the treatment of serious methicillin-resistant Staphylococcus aureus (MRSA) infections. However, sufficient clinical evidence to support the efficacy of this target C(min) has not been obtained. Even though the r...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Pharmacol Toxicol
Main Authors: Ueda, Takashi, Takesue, Yoshio, Nakajima, Kazuhiko, Ichiki, Kaoru, Ishikawa, Kaori, Takai, Yoshiko, Yamada, Kumiko, Tsuchida, Toshie, Otani, Naruhito, Takahashi, Yoshiko, Ishihara, Mika, Takubo, Shingo, Ikeuchi, Hiroki, Uchino, Motoi, Kimura, Takeshi
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7341468/
https://ncbi.nlm.nih.gov/pubmed/32641110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40360-020-00424-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados